NDAINTRAVENOUSSOLUTION
Approved
Jul 2019
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
2
Mechanism of Action
Thrombin Inhibitors
Pharmacologic Class:
Anti-coagulant
Clinical Trials (2)
Ticagrelor vs Clopidogrel in Non-ST Elevation Acute Coronary Syndrome Patients Undergoing PCI With Bivalirudin.
Started Sep 2014
34 enrolled
Non-ST Elevation Acute Coronary Syndrome
Switching From Fondaparinux to Bivalirudin or Unfractionated Heparin in ACS Patients Undergoing PCI
Started Jun 2007
100 enrolled
Acute Coronary Syndromes
Loss of Exclusivity
LOE Date
May 20, 2039
160 months away
Patent Expiry
May 20, 2039